| 000 | 01820 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518040027.0 | ||
| 264 | 0 | _c20200729 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1440-1681 | ||
| 024 | 7 |
_a10.1111/1440-1681.13101 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNarasimhan, Gayathri | |
| 245 | 0 | 0 |
_aOBG-like ATPase 1 inhibition attenuates angiotensin II-induced hypertrophic response in human ventricular myocytes via GSK-3beta/beta-catenin signalling. _h[electronic resource] |
| 260 |
_bClinical and experimental pharmacology & physiology _c08 2019 |
||
| 300 |
_a743-751 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphatases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAngiotensin II _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiomegaly _xchemically induced |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGTP-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 beta _xmetabolism |
| 650 | 0 | 4 |
_aHeart Ventricles _xpathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 650 | 0 | 4 |
_abeta Catenin _xmetabolism |
| 700 | 1 | _aHenderson, John | |
| 700 | 1 | _aLuong, Hien T | |
| 700 | 1 | _aRajasekaran, Namakkal Soorapan | |
| 700 | 1 | _aQin, Gangjian | |
| 700 | 1 | _aZhang, Jianyi | |
| 700 | 1 | _aKrishnamurthy, Prasanna | |
| 773 | 0 |
_tClinical and experimental pharmacology & physiology _gvol. 46 _gno. 8 _gp. 743-751 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/1440-1681.13101 _zAvailable from publisher's website |
| 999 |
_c29665776 _d29665776 |
||